{
  "company": "Eli Lilly",
  "ticker": "LLY",
  "sector": "Pharmaceuticals",
  "scannedDate": "2026-02-07",
  "searchesCompleted": 0,
  "urlsFetched": 1,
  "fetchFailures": [],
  "structuralFindings": {
    "suggestedModel": 4,
    "suggestedModelName": "Hybrid/Hub-and-Spoke",
    "suggestedOrientation": "Structural",
    "confidence": "High",
    "rationale": "Based on existing specimen classification. New observations from earnings/research session.",
    "aiTeamStructure": "Two new presidents joined the leadership team: Dr. Carole Ho (President of Lilly Neuroscience) and Anne White (President of Lilly Immunology), participating in their first earnings call. No specific A",
    "keyPeople": null,
    "investmentSignals": null,
    "observableMarkers": {}
  },
  "quotes": [
    {
      "text": "We recently announced a new collaboration with NVIDIA to open a co-innovation AI lab.",
      "speaker": "David Ricks",
      "speakerTitle": "CEO",
      "source": "pharma-earnings-q4-2025.json",
      "sourceUrl": "https://www.fool.com/earnings/call-transcripts/2026/02/04/eli-lilly-lly-q4-2025-earnings-call-transcript/",
      "sourceDate": "",
      "context": "Q4 2025 earnings call, discussing AI investments"
    },
    {
      "text": "This project will combine Lilly's scientific expertise with NVIDIA's leading technology to accelerate drug discovery.",
      "speaker": "David Ricks",
      "speakerTitle": "CEO",
      "source": "pharma-earnings-q4-2025.json",
      "sourceUrl": "https://www.fool.com/earnings/call-transcripts/2026/02/04/eli-lilly-lly-q4-2025-earnings-call-transcript/",
      "sourceDate": "",
      "context": "Describing the NVIDIA co-innovation lab purpose"
    }
  ],
  "sources": [
    {
      "name": "NVIDIA co-innovation AI lab announced",
      "url": "https://www.fool.com/earnings/call-transcripts/2026/02/04/eli-lilly-lly-q4-2025-earnings-call-transcript/",
      "type": "Earnings Call",
      "date": "2026-02-04",
      "notes": "NVIDIA co-innovation AI lab announced"
    }
  ],
  "summary": "NVIDIA co-innovation AI lab announced: Eli Lilly announced a new collaboration with NVIDIA to open a co-innovation AI lab combining Lilly's scientific expertise with NVIDIA's leading technology to accelerate drug discovery. The partnership New therapeutic area president structure: Two new presidents joined the leadership team: Dr. Carole Ho (President of Lilly Neuroscience) and Anne White (President of Lilly Immunology), participating in their first earnings call. No specific A Massive R&D pipeline acceleration: Daniel Skovronsky highlighted 36 active Phase III programs and 14 new Phase III programs initiated recently. 39 business development transactions completed in 2025. AI investment framed as supporting  $55B+ manufacturing expansion since 2020: Over $55 billion committed to manufacturing expansion since 2020, with AI as a separate innovation priority. New manufacturing sites in Wisconsin and North Carolina beginning production.",
  "openQuestions": [],
  "splitFrom": "pharma-earnings-q4-2025.json"
}
